Blepharospasm Global Clinical Trials Review, H2, 2015
Summary
GlobalData's clinical trial report, Blepharospasm Global Clinical Trials Review, H2, 2015 provides an overview of Blepharospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Blepharospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Blepharospasm 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Blepharospasm to Ophthalmology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Blepharospasm to Ophthalmology Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Blepharospasm 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Blepharospasm Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Blepharospasm 29
Apr 20, 2015: Merz Neurosciences to Present Key Clinical Data at the Annual Meeting of the American Academy of Neurology 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Merz GmbH & Co. KGaA 30
Clinical Trial Overview of Merz GmbH & Co. KGaA 30
Merz Pharma GmbH & Co. KgaA 31
Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA 31
Allergan Plc 32
Clinical Trial Overview of Allergan Plc 32
Merz Pharmaceuticals GmbH 33
Clinical Trial Overview of Merz Pharmaceuticals GmbH 33
Ipsen S.A. 34
Clinical Trial Overview of Ipsen S.A. 34
Medy-Tox Inc. 35
Clinical Trial Overview of Medy-Tox Inc. 35
JIN CO., LTD. 36
Clinical Trial Overview of JIN CO., LTD. 36
Hugel Pharma Co. Ltd. 37
Clinical Trial Overview of Hugel Pharma Co. Ltd. 37
GlaxoSmithKline Plc 38
Clinical Trial Overview of GlaxoSmithKline Plc 38
Allergan, Inc. 39
Clinical Trial Overview of Allergan, Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
Aichi Medical University 40
Clinical Trial Overview of Aichi Medical University 40
Loma Linda University 41
Clinical Trial Overview of Loma Linda University 41
National Institute of Neurological Disorders and Stroke 42
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 42
St. Joseph's Healthcare Hamilton 43
Clinical Trial Overview of St. Joseph's Healthcare Hamilton 43
Sun Yat-sen University 44
Clinical Trial Overview of Sun Yat-sen University 44
Five Key Clinical Profiles 45
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 84
List Of Tables
List of Tables
Blepharospasm Therapeutics, Global, Clinical Trials by Region, 2015* 7
Blepharospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Blepharospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Blepharospasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Blepharospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Blepharospasm Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Blepharospasm to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 13
Blepharospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Blepharospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Blepharospasm to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 16
Blepharospasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Blepharospasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Blepharospasm Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Blepharospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Blepharospasm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Blepharospasm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Blepharospasm Therapeutics, Global, Terminated Clinical Trials, 2015* 23
Blepharospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Blepharospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Blepharospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Blepharospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Blepharospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz GmbH & Co. KGaA, 2015* 30
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2015* 31
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 32
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharmaceuticals GmbH, 2015* 33
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2015* 34
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Medy-Tox Inc., 2015* 35
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by JIN CO., LTD., 2015* 36
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Hugel Pharma Co. Ltd., 2015* 37
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 38
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 39
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Aichi Medical University, 2015* 40
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Loma Linda University, 2015* 41
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2015* 42
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Healthcare Hamilton, 2015* 43
Blepharospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015* 44
List Of Figures
List of Figures
Blepharospasm Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Blepharospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Blepharospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Blepharospasm Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Blepharospasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Blepharospasm Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Blepharospasm to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 13
Blepharospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Blepharospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Blepharospasm to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 16
Blepharospasm Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 17
Blepharospasm Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Blepharospasm Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Blepharospasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Blepharospasm Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Blepharospasm Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Blepharospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Blepharospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Blepharospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Blepharospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Blepharospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 82
